← Back to all trials
Completed
NCT07944534
Burden of Infections and Antimicrobial Resistance in Neonatal Intensive Care Units in Argentina (PREV-AR NICU): A National Point-Prevalence Study
Conditions: Healthcare-associated Infections, Antimicrobial Resistance
Sex: All
Ages: 1 Day – N/A
Healthy volunteers: No
Enrollment: 548
Sponsor: Hospital Italiano de Buenos Aires
Location: Hospital Italiano de Buenos Aires Buenos Aires Buenos Aires
Summary
PREV-AR NICU was a national, multicenter, cross-sectional point-prevalence study conducted in 58 neonatal intensive care units (NICUs) in Argentina during April 2026. All patients present in a participating NICU during a 24-hour period were included. Active infection was classified as infection without sepsis, probable sepsis, confirmed sepsis, or septic shock. Colonization by multidrug-resistant organisms (MDRO) was assessed by rectal and nasal swabs. Patients were followed for in-NICU mortality. Mixed-effects logistic regression was used to identify independent predictors of infection and mortality.
Eligibility Criteria
Inclusion Criteria:
* All patients present in a participating neonatal intensive care unit (NICU) during the 24-hour study period (beginning at 08:00) on the site-selected study date between 8 and 12 April 2026
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT07944534). StuddyBuddy aggregates publicly available trial information.